Stock price of Nanoviricides Inc. (OTC:NNVC) has been changing a lot over the past days. Although NNVC closed the week with 
a loss, yesterday the stock price jumped up 1.80% and its traded volume increased. Maybe Nanoviricides still has a chance to hold the gain due to the latest news released.
Yesterday, the company reported the acquisition of a light industrial building for laboratory facilities and a future cGMP production. The announcement stated that financing for the acquisition was provided by some private investors, including the President of Inno-Haven who sold some of his shares of NNVC.
Claiming that this financing approach provided the best value for the company and its shareholders, this news may push up NNVC stock price even higher. Though, considering the fact that the company’s President has been selling since June, the disposed NNCV shares substantially increased.
Meanwhile, the last quarterly report of the company was filed in May, this year. Since then, no financial data has been revealed.
As of March 31, this year, NNVC has registered:
* $8.2 million current assets
* $809k current liabilities
* $21.9 million accumulated deficit
* $2.5 million in net loss
* $0 revenues [BANNER]
Nothing special in the report, apart from the huge losses that haven’t been covered. While, at the same time, investors keep waiting for the new 10-Q report of Nanoviricides.
However, instead of providing the numbers, the company’s President makes unreasonable investments, while hoping for an FDA approval.
